For example, 13 novel interactors of MPeM-associated genes were associated with prostatic neoplasms (MPeM genes are shown in bold): MET-SLC26A4, DPYD-SULT2A1, CTNNB1-LAMB2, IRS2-MPO, HRAS-ZFP36L2, VEGFB-UCP3, PRDM1-HPGD, NSD1-NPR3, KEAP1-SLC5A5, MET-FOXA3, RHEB-NOS3, HRAS-HBG1 and JAK1-CBR1. This evidence concerns the gene HRAS and prostate neoplasm.